Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement

Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement

Abstract Background The study aimed to assess the correlation between the monitoring frequency of PT-INR and the long-term prognosis in patients with mechanical heart valve (MHV) replacement after discharge. Methods This single-center, observational study enrolled patients who underwent MHV replacem...

Full description

Bibliographic Details
Main Authors:	Le Geng, Jiaxi Gu, Minghui Li, Hong Liu, Haoliang Sun, Buqing Ni, Weidong Gu, Yongfeng Shao, Mingfang Li, Minglong Chen
Format:	Article
Language:	English
Published:	BMC 2023-06-01
Series:	BMC Cardiovascular Disorders
Subjects:	Mechanical heart valve Warfarin Prothrombin time-international normalized ratio Monitoring frequency
Online Access:	https://doi.org/10.1186/s12872-023-03293-w

Similar Items

STANDARDIZATION OF PROTHROMBIN TIME TEST AND EVALUATION OF QUALITY OF PATIENT MANAGEMENT WITH WARFARIN
by: A.H ZARGARZADEH, et al.
Published: (2000-12-01)

Evaluation of the marker of hypercoagulability prothrombin fragment F 1+2 in patients with mechanical or biological heart valve prostheses
by: Claudia Natália Ferreira, et al.
Published: (2002-11-01)

Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
by: Pall T. Onundarson, et al.
Published: (2021-10-01)

A sensitivity comparison of the Quick and Owren prothrombin time methods in oral anticoagulant therapy
by: Juha Eero Horsti
Published: (2009-09-01)

Use and effectiveness of a two‐level initiation strategy for fixed‐dose prothrombin complex concentrate according to the initial international normalized ratio in an emergency department in Japan
by: Kei Suzuki, et al.
Published: (2021-01-01)

Dose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification
by: Hideki Hashimoto, et al.
Published: (2017-11-01)

Emergency intensive care unit pharmacist’s intervention may reduce time to four-factor prothrombin complex concentrate administration: a retrospective study
by: Shoichi Imanaka, et al.
Published: (2020-04-01)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
by: Eman M. Mansory, et al.
Published: (2021-05-01)

Valve-in-valve/valve-in-ring transcatheter mitral valve implantation vs. redo surgical mitral valve replacement for patients with failed bioprosthetic valves or annuloplasty rings: A systematic review and meta-analysis
by: Xiufan Xu, et al.
Published: (2023-05-01)

Dose-dependent artificial prolongation of prothrombin time by interaction between daptomycin and test reagents in patients receiving warfarin: a prospective in vivo clinical study
by: Makoto Saito, et al.
Published: (2017-04-01)

Prothrombin expression in cancer-derived cell lines
by: Dunjić Sofija, et al.
Published: (2019-01-01)

Prothrombin Time, an Indicator for Psoriasis Activity: A Case - Control Study
by: Majid Morovati-Sharifabad, et al.
Published: (2020-10-01)

The outcome of three-factor Prothrombin Complex Concentrate (3F-PCC) in warfarin reversal: A single center retrospective cohort study
by: Hock Peng Koh, et al.
Published: (2020-12-01)

Gestational complications of the prothrombin G20210A mutation related to prothrombin activity
by: M. G. Nikolaeva, et al.
Published: (2020-07-01)

The effect of COVID-19 pandemic on time in therapeutic range in patients using warfarin
by: Adem Aktan, et al.
Published: (2022-01-01)

Mechanical prosthetic valve disease is related with an increase in depression and anxiety disorder
by: Yasemin Turker, et al.
Published: (2015-02-01)

Clinical and laboratory manifestations of the prothrombin gene mutation in women of reproductive age
by: Momot AP, et al.
Published: (2019-08-01)

The appearance of molecules of prothrombin origin in blood upon development of atherothrombotic and cardioembolic ischemic stroke
by: N. Raksha, et al.
Published: (2016-07-01)

A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma
by: Cecilia Augustsson, et al.
Published: (2024-01-01)

Predictive Value of the Prothrombin Time-International Normalized Ratio to Albumin Ratio in the Prognosis of Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
by: Sheng Y, et al.
Published: (2023-10-01)

Prothrombin time in retinitis pigmentosa
by: Vinchurkar Manisha
Published: (1998-01-01)

Modified application of SAMe-TTR scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants
by: Seong Won Jeon, et al.
Published: (2024-05-01)

Comparison of 4F‐PCC in obese and nonobese patients with life‐threatening bleeding or requiring emergent surgery
by: Jessica Rimsans, et al.
Published: (2021-12-01)

Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature
by: Matthew Laubham, et al.
Published: (2018-05-01)

One-Year Follow-Up of Morbidity and Mortality in Mechanical Valve Replacement Patients at a Newly Established Cardiac Center in a Developing Country
by: Muhammad Tariq, et al.
Published: (2024-12-01)

Prothrombin Complex Concentrate in Emergency Department
by: Višnja Nesek Adam, et al.
Published: (2022-01-01)

Application of low-intensity anticoagulation after On-X mechanical aortic valve replacement
by: Kun Zou, et al.
Published: (2025-01-01)

Efficacy of Prothrombin Complex Concentrate Treatment in Patients with Liver Coagulopathy Who Underwent Various Invasive Hepatobiliary and Gastrointestinal Procedures
by: Cosmas Rinaldi A. Lesmana, et al.
Published: (2016-06-01)

The progress of prothrombin time measurement
by: Juha Eero Horsti
Published: (2009-12-01)

Safety and efficacy of using portable coagulation monitor for INR examination after left-sided mechanical prosthetic valve replacement
by: Yue Shen, et al.
Published: (2022-12-01)

Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01)

Potential clinical benefits of warfarin in end‐stage cancers: A retrospective analysis
by: Osamu Imataki, et al.
Published: (2023-01-01)

Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery
by: Tomoki Takase, et al.
Published: (2018-05-01)

A note on the prothrombin time abnormality in the patients with amebic liver abscess
by: Viroj Wiwaniikit, et al.
Published: (2006-12-01)

Rosendaal linear interpolation method appraising of time in therapeutic range in patients with 12-week follow-up interval after mechanical heart valve replacement
by: Xiliang Zhu, et al.
Published: (2022-09-01)

The Association between Preeclampsia and Defined Polymorphisms in Prothrombin and Coagulation Factor V Genes
by: Zohreh Salari, et al.
Published: (2016-09-01)

Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review
by: Christina R. Evans, et al.
Published: (2022-05-01)

Quick or Owren prothrombin time methods: possibilities and limitations (literature review)
by: R.A. Zatsarynnyi, et al.
Published: (2024-09-01)

Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
by: Javad Dehbozorgian, et al.
Published: (2009-06-01)

Combining portable coagulometers with the Internet: A new model of warfarin anticoagulation in patients following mechanical heart valve replacement
by: Yu Huang, et al.
Published: (2022-10-01)